FILED AND SPONSOR-REPORTED ETF HOLDINGS
ELVN Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding ELVN
6 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 1.807806% | 2026-01-30 (baseline) | 2026-04-30 |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 1.797188% | 2026-04-30 (baseline) | 2026-04-30 |
| OPTZ | Optimize Strategy Index ETF | 0.283015% | 2026-03-31 | 2026-03-31 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.10174% | 2026-01-31 (baseline) | 2026-04-30 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.022735% | 2026-01-31 (baseline) | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.002753% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding ELVN
| ETF | Fund | Added / first observed | Removed / first absent |
|---|---|---|---|
| CANC | Tema Oncology ETF | 2025-11-30 (baseline) | 2026-02-28 |